News

Bio-Works Technologies AB has  been awarded  over 1.5M SEK by Vinnova, the Swedish grant authority, to develop [...]

Bio-Works opens a US sales office, marking a key step in expanding its presence in the world's largest biopharmaceutical market.

Bio-Works' WorkBeads resins are used in full-scale commercial production of an FDA-approved biopharmaceutical, validating the product's quality and reliability.

Bio-Works establishes a Scientific Advisory Board of leading experts to guide its research and product development strategy.

Bio-Works raises its new customer target for 2018, reflecting strong commercial momentum and growing market demand.

Bio-Works launches WorkBeads affimAb, a novel affinity resin designed for the purification of next-generation biological pharmaceuticals.

Bio-Works reports a 125% increase in its customer base during 2018, reflecting strong commercial growth across all key markets.

Bio-Works publicerar sin bokslutskommuniké för januari–december 2018 med finansiella resultat och viktiga händelser.

Bio-Works achieves ISO 9001:2015 certification, demonstrating its commitment to quality management and regulatory compliance.

Bio-Works presents investment case at BioStock, highlighting its technology and growth opportunities in Nordic life sciences.

Bio-Works presents at the Vator Securities Unicorn Summit, showcasing its technology and growth strategy to investors.

Bio-Works releases its Q1 2019 quarterly report covering financial performance and key operational developments.

Bio-Works participates in Småbolagsdagen, presenting its business and growth strategy to Swedish investors and analysts.

Bio-Works publishes the report from its Extraordinary General Meeting held on 12 June 2019.

Bio-Works signs a three-year supply agreement, reinforcing customer confidence and providing a stable long-term revenue base.

Bio-Works announces a new CEO appointment, marking a new chapter in the company's leadership and strategic direction.

Bio-Works confirms uninterrupted operations during the COVID-19 pandemic, assuring customers of continued product supply.

Bio-Works reports strong sales growth in Q1 2020, demonstrating resilient demand for its chromatography products.

Bio-Works appoints Jonathan Royce as its new CEO, bringing extensive life sciences expertise to lead the company's next growth phase.

Bio-Works expands its WorkBeads product line with the launch of WorkBeads NiMAC and WorkBeads Dsalt chromatography resins.

Bio-Works secures two orders from a US customer totaling SEK 1.1 million, reflecting growing North American demand.

Bio-Works signs a licensing agreement with Amicogen Inc. to establish local agarose resin manufacturing in South Korea.

Bio-Works launches two new kits designed for efficient peptide purification, expanding its product portfolio for researchers.

Bio-Works Technologies AB successfully passes its annual ISO 9001:2015 audit, reaffirming its quality management commitment.

Bio-Works signs an exclusive distribution deal with MicroAnalytix to serve customers in Australia and New Zealand.

Bio-Works signs a distribution agreement with S. Amit Speciality Chemicals to strengthen its presence in the Indian market.

Bio-Works expands its European distribution network by partnering with BIA d.o.o. to cover Croatia and Slovenia.

Bio-Works provides protein purification training to African research centers, building scientific capacity across the continent.

Bio-Works Technologies AB publishes its Annual Report for 2022, reflecting a year of meaningful progress for the company.

A newly issued patent by the Swedish Intellectual Property Office grants Bio-Works Technologies AB rights to manufacture agarose beads using natural vegetable oils instead of fossil-based oils, enabling greener chromatography.

Bio-Works Technologies AB publishes its Annual Report for 2023, detailing the company's continued journey and strategic developments.

Zepteon, Inc. partners with Bio-Works Technologies AB to expand distribution of Glycap-3A chromatography columns, enhancing market reach in the US and EU.

The biopharmaceutical landscape is evolving rapidly. While traditional monoclonal antibodies (mAbs) remain a cornerstone of [...]

The demand for monoclonal antibodies (mAbs) continues to grow rapidly — from innovative bispecifics and [...]

WorkBeads SEC resins WorkBeads™ SEC resins are highly cross-linked, rigid agarose beads, optimized for preparative [...]

Virus purifications Viruses are very common and significant infectious agents that cannot be treated with [...]

Introduction For the moment the purification processes of veterinary viral vaccines are generally simple and [...]

Chromatography agarose resins […]

Introduction Lactoferrin is a globular glycoprotein found in secretory fluids of mammals. It controls the [...]

Introduction There is often a need for removing unwanted salt or low molecular weight compounds, [...]

Introduction […]

Introduction Conductivity, pH, residence time and the pI of the protein effects the binding of [...]

Introduction The prepacked BabyBio™ columns for ion exchange chromatography (IEX) are designed for easy and [...]

Introduction Purification of biomolecules from complex feeds is often best carried out using combinations of [...]

Introduction Recombinant DNA technology has long been used to produce therapeutic insulin and, since most [...]

Oligonucleotides as therapeutic molecules Short oligonucleotides have become established as important molecules in therapeutics, primarily [...]

Introduction Oligonucleotides with a phosphorothioate backbone Oligonucleotide (ON)-based therapeutics is an evergrowing market with an [...]

Chromatography agarose resins Agarose-based chromatography resins consisting of highly cross-linked porous beads have been used [...]

Introduction Since oligonucleotides (ONs) are mainly synthetically produced by solid-phase synthesis it is easy to [...]

Introduction Ion Exchange Chromatography (IEX) is a powerful and widely used technique for separating and [...]

Introduction Oligonucleotide synthesis provides custom-made oligonucleotides. The purity of oligonucleotide preparations produced by solid-phase synthesis [...]

  Solid-phase synthesis of oligonucleotides generally give material of rather high purity. However, for many [...]

Introduction Efficient purification of therapeutic molecules is of the utmost importance. Equally important, is the [...]

The Study: A Comparative Analysis Our study, published in the Journal of Chromatography A, focused [...]

Introduction RNA molecules have emerged as important molecules in therapeutics, primarily in the form of [...]

Introduction Solid-phase synthesis of oligonucleotides generally gives material of rather high purity. However, for many [...]

Results from IMAC purifications depend both on the chelated metal ion and the chelator itself [...]

Introduction Immobilized Metal Affinity Chromatography (IMAC) is the commonest technique for purification of His-tagged proteins. [...]

Introduction Immobilized Metal Ion Affinity Chromatography (IMAC) utilizes the affinity of histidine, cysteine and tryptophan [...]

Introduction The rapidly growing monoclonal antibody (mAb) market and the increasing demand for improved process [...]

When it comes to optimizing and refining your purification processes, nothing can surpass the precision [...]

Introduction A new protein A chromatography resin has been designed for purification of mAbs, Gabs [...]

Introduction The purity requirements are high for monoclonal antibodies (mAbs). Using protein A chromatography resins [...]

Introduction A protein A ligand designed to give high alkaline stability was immobilized on WorkBeads™ [...]

An expanding mAb market drives the need for high-efficient protein A resins Monoclonal antibodies (mAbs) [...]

Therapies based on monoclonal antibodies (mAbs) currently represent the largest and fastest developingbiopharmaceutical market. The [...]

Discover the fascinating principle behind hydrophobic interaction chromatography and how it is used in scientific [...]

Chromatography is a popular purification technique used in biomanufacturing to separate and isolate your target [...]

Today, monoclonal antibodies (mAbs) represent the largest and most progressive biopharmaceutical market. The mAbs used [...]

Therapeutic peptides hold an important position amongst pharmaceutical compounds due to their relatively small size [...]

The purity requirements for therapeutic peptides are very stringent, but synthesis generates a crude peptide [...]

More than 80 peptide drugs have been approved by the FDA so far, and many [...]

Boston, MA / Uppsala, Sweden – In a significant move to expand their market reach [...]

In 1982 a new type of pharmaceutical appeared on the market. Recombinant human insulin was [...]

Pharma 4.0, the latest buzzword in the pharmaceutical industry, has the potential to transform the [...]

One year ago, I wrote that opportunities tend to be disguised as hard work, and [...]

Discover how protein A resins can enhance the purification process of ADCs and maximize their [...]

Learn how anion exchange chromatography can be used to effectively separate full and empty capsids [...]

In a groundbreaking move towards sustainable chromatography practices, a recently issued patent, dated September 23, [...]

Discover effective solutions to common challenges encountered in Hydrophobic Interaction Chromatography (HIC) with this comprehensive [...]

Discover the secrets of optimizing protein separations using hydrophobic interaction chromatography and achieve optimal results. [...]

Traditional Chinese medicine (TCM) is an ancient traditional medical system that has developed over thousands [...]

Advanced therapy medicinal products (ATMPs) are human therapeutics that are based on genes, tissues or [...]

The landscape of medical therapies is shifting faster than ever, and monoclonal antibodies (mAbs) are [...]

Therapeutic oligonucleotides are relatively simple molecules in the world of molecular biology. They are single- [...]

“Bio-Works has both the ambition and a good position for further expansion.” With these words, [...]

Since the spring of 2022 Bio-Works has been involved in a project to spread the [...]

The demand for a more environmentally friendly production of pharmaceuticals is increasing and along with [...]

At BPI Boston this year we were honored to talk to Jean Bender who has [...]

At BPI Boston we chatted to Quinnie Wong, Director of Diversity Equity and Inclusion (DEI) [...]

At BPI in Boston this September we were lucky enough to get to talk to [...]

Another of the great meetings we had at BPI in Boston was with Tom Ransohoff [...]

At the BioProcess International in Boston 27-30 Sept we had the pleasure to talk to [...]

We talked to Wolfgang Winter, Informatics Platform R&D Director at Agilent after his very interesting [...]

 At the 2022 ACHEMA conference we had the pleasure of getting to talk to Slim [...]

We talked to Wolfgang Winter, Informatics Platform R&D Director at Agilent after his very interesting [...]

Pharma 4.0 is ISPE’s roadmap to introduce Industry 4.0, also called the Smart Factory, to [...]

Bio-Works Technologies AB (Uppsala, Sweden) and BIA d.o.o. (Ljubljana, Slovenia) have signed a distribution agreement [...]

Bio-Works Technologies AB has signed a non-exclusive Distribution Agreement with S. Amit Speciality Chemicals Private Limited to import, store, distribute, market, promote [...]

Bio-Works Technologies AB has signed an exclusive Distribution Agreement with Microanalytix Pty Ltd for the import, storage, distribution, marketing and sales [...]

Today, Bio-Works successfully passed the annual ISO-9001: 2015 inspection. The external auditor from Intertek has [...]

In order to improve the convenience of the resin screening process, Bio-Works announces the launch of [...]

Bio-Works Technologies AB has signed a licensing agreement with Amicogen Inc to establish local production [...]

Bio-Works has received two orders worth a total of SEK 1.1 million from an American [...]

Have you experienced how Nickel-charged chromatography columns used for purifying His-tagged proteins lose their blue [...]

Bio-Works is constantly striving to develop new products that address customer needs and that are [...]

Do you find yourself having to deal with a very low yield of your target [...]

This week, Jonathan Royce assumed the role of chief executive officer of Bio-Works Sweden (BIOWKS.ST). [...]

If you’re purifying therapeutic oligos you’ll need to clean the desalting resins afterwards in a [...]

Mats Johnson, CEO of Bio-Works, will be presenting at the Vator Securities Unicorn Summit on Thursday [...]

Process modelling of chromatographic behavior, in an industrial setting, can be a useful tool in [...]

Bio-Works shows strong sales growth during Q1 2020 Bio-Works Technologies increases sales by 230 percent [...]

COVID-19 update from Bio-Works Times are at present difficult and challenging, but Bio-Works want to [...]

  The Board of Directors of Bio-Works Technologies AB has decided to appoint Jonathan Royce [...]

Bio-Works Technologies has signed a supply agreement with one of its production customers in Eastern [...]

Press release, Stockholm 12 June 2019 (Swedish version) […]

Bio-Works Technologies AB Quarterly report Q1 2019 Period 1 January – 31 March 2019 in [...]

Mats Johnson, CEO of Bio-Works will be presenting for investors at the BioStock live STHLM [...]

Amicogen Inc. is the largest shareholder in Bio-Works Technologies AB as of today, with slighty [...]

Pressmeddelande 22 februari 2019 kl. 12:00 […]

I detta avsnitt av Vatorpodden intervjuas Bio-Works VD Mats Johnson och styrelseordförande Thomas Pollare. De [...]

Press release April 12, 2018 Bio-Works’ separation media, WorkBeads, has become standard for the production [...]

Press release Februari 23 2018 Bio-Works has received an order of 1,0 million SEK from [...]

Pressmeddelande den 23 februari 2018, kl: 07:37 Bio-Works har erhållit en order värd 1,0 miljon [...]

Bio-Works offentliggör prospekt inför listning på Nasdaq First North […]

Press release October 9, 2018 Bio-Works today announces the launch of WorkBeads affimAb for purification [...]

Mats Johnson will from today, August 1 2017, take over the responsibility as CEO for [...]

Mats Johnson, Bio-Works CEO will present at Småbolagsdagen on 3rd June On Monday June 3rd, [...]

Press release March 20th 2018 Bio-Works has opened a sales office in Philadelpia, USA to [...]

Press release March 13, 2019   […]

Press release October 8, 2018 After the third quarter of 2018, Bio-Works has 203 customers, [...]

Press release February 7, 2019 Bio-Works had 236 active customers at the end of 2018. [...]

Bio-Works Technologies AB is pleased to announce that its recent new share issue has been [...]

Press release September 10, 2018 Bio-Works has recruited four distinguished scientists with industrial experience to [...]

Changing from purification products based on synthetic polymers to agarose-based chromatography will increase the purity [...]

Just before the Christmas break, Lars, Haneskog, Bio-Works R&D Director, presented a new and proven [...]

Improving the downstream bioprocess economy depends on fine-tuning an enormous range of parameters, from culture [...]

A critical and fundamental factor in both analytical and preparative chromatography is the use of [...]

Filtering is crucial in order to protect the packed column from all solid particles in [...]

Peptide therapeutic agents are enjoying increasing success but they are challenging to produce and, not [...]

The environmental impact of pharmaceutical R&D and production is considerable. Although the industry is rather [...]

As our understanding of diseases at the molecular level increases, so does the potential for [...]

Immobilized Metal Ion Affinity Chromatography (IMAC) is used for purification of His-tagged proteins. Ni-NTA based [...]

Designing an optimized purification process means maximizing yield and purity, and at the same time [...]

When an IEX resin has been used for some time, impurities may build up in [...]

The global diabetes pandemic has created a massive demand for insulin, especially in China, which [...]

Recovery of your biologically active target substance is a priority, and it’s important to check for [...]

When it comes to many serious and challenging diseases, healthcare has reached a point of [...]

Choosing a mammalian cell line or other type of host is as critical a question [...]

Since the 1980’s, monoclonal antibodies (mAbs) have revolutionized healthcare and continue to do so. A [...]

The healthcare sector and developers of new pharmaceuticals are facing increasing challenges, along with pressure [...]

Can you generalize about something as broad as protein purification strategy? Surely it depends on [...]

The market for monoclonal antibodies (mAbs) is constantly growing as mAb therapies are generally considered [...]

Five of the top ten best selling drugs in 2017 were mAbs and the global [...]

In 2015, the monoclonal antibodies (mAbs) market was estimated to be USD 85,4 billion and [...]

In short, an efficient protein A resin is one that will not only help you [...]

What are the benefits of introducing multimodal ion exchange chromatography as a guard column and [...]

Monoclonal antibodies, mAbs, form a well-established, technologically advanced segment of the pharmaceutical industry offering hope [...]